- Home
- ALTO vs CATX Comparison
ALTO vs CATX Comparison
Compare ALTO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | CATX |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.7M | 414.0M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALTO | CATX |
|---|---|---|
| Price | $4.64 | $2.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | ★ 2.8M | 2.1M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $917,927,000.00 | N/A |
| Revenue This Year | $6.66 | N/A |
| Revenue Next Year | $0.43 | N/A |
| P/E Ratio | $99.40 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $1.96 |
| 52 Week High | $6.11 | $6.16 |
Technical Indicators
Market Signals| Indicator | ALTO | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 39.85 | 40.53 |
| Support Level | $4.27 | $2.86 |
| Resistance Level | $5.07 | $2.96 |
| Average True Range (ATR) | 0.45 | 0.20 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 3.53 | 12.50 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.